GGHC
CMD

Gilder Gagnon Howe & Co’s Cantel Medical Corporation CMD Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-23,398
Closed -$793K – 286
2013
Q4 		$793K Buy
+23,398
New +$811K 0.01% 213

Other funds holding CMD

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Gilder Gagnon Howe & Co's CMD Position: Q1 2014 in Review

Gilder Gagnon Howe & Co sold out of Cantel Medical Corporation (CMD) in Q1 2014, closing a stake of 23,398 shares — an estimated $793K sold.

Gilder Gagnon Howe & Co first reported a position in CMD in Q4 2013 and held it in 1 quarter. The position peaked at $793K in Q4 2013. 145 funds tracked by Wall St. Rank hold CMD as of Q1 2014.

  • Gilder Gagnon Howe & Co reported no remaining Cantel Medical Corporation position as of Q1 2014 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 23,398 Cantel Medical Corporation shares in Q1 2014, an estimated $793K.
  • Gilder Gagnon Howe & Co first reported a position in Cantel Medical Corporation in Q4 2013 and held it in 1 quarter.
  • Gilder Gagnon Howe & Co's Cantel Medical Corporation position peaked at $793K in Q4 2013.
  • 145 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2014.

Based on Gilder Gagnon Howe & Co's 13F filing for Q1 2014, filed 9 May 2014.